Sentinel lymphadenectomy: An alternative to axillary lymphadenectomy in breast cancer;Sentinel-lymphadenektomie: Eine alternative zur axillaren lymphadenektomie beim mammakarzinom

Schweizerische Medizinische Wochenschrift

Volumn 128, Issue 44, 1998, Pages 1730-1736

  Berclaz, G ^a   Crazzolara, A O ^a   Altermatt, H J ^b   Aebi, S ^a   Fey, M F ^a   Hanggi W ^a   Dreher, E ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b Pathologie Länggasse   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; PROGNOSIS;

EID: 0032585227     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT. Assessment of morbidity from complete axillary dissection. Br J Cancer 1992;66:136-8.
2. Kissin MW, Querci della Rovere G, Easton D, Westbury G. Risk of lymphoedema following the treatment of breast cancer. Br J Surg 1986;73:580-4.
3. Ryttov N, Holm NV, Qvist N, Blichert-Toft M. Influence of adjuvant irradiation on the development of late arm lymphedema and impaired shoulder mobility after mastectomy for carcinoma of the breast. Acta Oncol 1988;27:667-70.
4. Davies GC, Millis RR, Hayward JL. Assessment of axillary lymph node status. Ann Surg 1980;192:148-51.
5. Kissin MW, Thompson EM, Price AB, Slavin G, Kark AE. The inadequacy of axillary sampling in breast cancer. Lancet 1982/I:1210-2.
6. Kjaergaard J, Blichert-Toft M, Andersen JA, Rank F, Pedersen BV, and the Danish Breast Cancer Cooperative Group. Probability of false negative nodal staging in conjunction with partial axillary dissection in breast cancer. Br J Surg 1985;72:365-7.
7. Rosen PP, Lesser ML, Kinne DW, Beattie EJ. Discontinuous or "skip" metastases in breast carcinoma. Analysis of 1228 axillary dissections. Ann Surg 1983;197:276-83.
8. Veronesi U, Rilke F, Luini A, Sacchini V, Galimberti V, Campa T, et al. Distribution of axillary node metastases by level of invasion. An analysis of 539 cases. Cancer 1987; 59:682-7.
9. Morton DL, Wen D-R, Wong JH, Economou JS, Cagle LA, Storm FK, et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992;127: 392-9.
10. Giuliano AE, Kirgan DM, Guenther JM, Morton LM. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 1994;220:391-401.
11. Krag DN, Weaver DL, Alex JC, Fairbank JT. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 1993; 2:335-40.
12. Veronesi U, Paganelli G, Galimberti V, Viale G, Zurrida S, Bedoni M, et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864-7.
13. Berg JW. The significance of axillary node levels in the study of breast carcinoma. Cancer 1955;8:776-8.
14. Borgstein PJ, Meijer S, Pijpers R. Intradermal blue dye to identify sentinel lymph node in breast cancer. Lancet 1997; 349:1668-9.
15. Moffat FL, Senofsky GM, Davis K, Clark KC, Robinson DS, Ketcham AS. Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol 1992;51:8-13.
16. Moore MP, Kinne DW. Axillary lymphadenectomy: a diagnostic and therapeutic procedure. J Surg Oncol 1997;66:2-6.
17. Albertini JJ, Lyman GH, Cox C, Yeatman T, Balducci L, Ku N, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996;276:1818-22.
18. Stewart KC, Lyster DM. Interstitial lymphoscintigraphy for lymphatic mapping in surgical practice and research. J Invest Surg 1997;10:249-62.
19. Reuhl TH, Kaisers H, Markwardt J, Haensch W, Hohenberger P, Schlag PM. Axillaausräumung bei klinisch nodal-negativem Mammakarzinom. Kann die Indikation durch "sentinel node"-Nachweis individualisiert werden? Dtsch Med Wochenschr 1998;123:583-7.
20. Alex JC, Krag DN. The gamma-probe-guided resection of radiolabeled primary lymph nodes. Surg Oncol Clin N Am 1996;5:33-41.
21. Dale PS, Williams JT. Axillary staging utilizing selective sentinel lymphadenectomy for patients with invasive breast carcinoma. Am Surg 1998;64:28-31.
22. Pijpers R, Meijer S, Hoekstra OS, Collet GJ, Comans EFI, Boom RPA, et al. Impact of lymphoscintigraphy on sentinel node identification with Technetium-99m-colloidal albumin in breast cancer. J Nucl Med 1997;38:366-8.
23. Guenther JM, Krishnamoorthy M, Tan LR. Sentinel lymphadenectomy for breast cancer in a community managed care setting. Cancer J Sci Am 1997;3:336-40.
24. Giuliano AE, Jones RC, Brennan M, Statman R. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15:2345-50.
25. Büchels HK, Wagner T, Vogt H. Mammacarcinomstaging mittels Sentinel-Lymphadenektomie. Chirurg 1997;68: 1258-61.
26. Gulec SA, Moffat FL, Carroll RG, Krag DN. Gamma probe guided sentinel node biopsy in breast cancer. Q J Nucl Med 1997;41:251-61.
27. Cox CE, Pendas S, Cox JM, Joseph E, Shons AR, Yeatman T, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998;227: 645-53.
28. Fisher ER, Swamidoss S, Lee CH, Rockette H, Redmond C, Fisher B. Detection and significance of occult axillary node metastases in patients with invasive breast cancer. Cancer 1978;42:2025-31.
29. Nasser IA, Lee AK, Bosari S, Saganich R, Heatley G, Silverman ML. Occult axillary lymph node metastases in "node-negative" breast carcinoma. Hum Pathol 1993;24:950-7.
30. Giuliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL. Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 1995;222:394-401.
31. Turner RR, Ollila DW, Krasne DL, Giuliano AE. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma. Ann Surg 1997;3:271-8.
32. Rosen PP, Saigo PE, Braun DW Jr, Beattie EJ Jr, Kinne DW. Occult axillary lymph node metastases from breast cancers with intramammary lymphatic tumor emboli. Am J Surg Pathol 1982;6:639-41.
33. Dowlatshahi K, Fan M, Snider HC, Habib FA. Lymph node micrometastases from breast carcinoma. Reviewing the dilemma. Cancer 1997;80:1188-97.
34. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 1990;335:1565-8.
35. de Mascarel I, Bonichon F, Coindre JM, Trojani M. Prognostic significance of breast cancer axillary node micrometastases assessed by two special techniques: reevaluation with longer follow-up. Br J Cancer 1992;66:523-7.
36. McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC, Wright RG. Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 1996;73:88-95.
37. Silverstein MJ. Recent advances. Diagnosis and treatment of early breast cancer. Br Med J 1997;314:1736-9.